Confidence Interval Criteria for Assessment of Dose Proportionality

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pharmaceutical Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1026451721686PMID 11145235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of Testosterone in Hypogonadal Men After Transdermal Delivery: Influence of Dose

  1996cited by this paper
• Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party

  1995cited by this paper
• Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.

  1995cited by this paper
• Dose-response in pharmacokinetics

  1994influential reference
• Influence of Dose Range on Degree of Nonlinearity Detected in Dose-Proportionality Studies for Drugs with Saturable Elimination: Single-Dose and Steady-State Studies

  1993cited by this paper
• Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl Metabolite

  1992cited by this paper
• Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses

  1992cited by this paper
• Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjects.

  1988cited by this paper
• Bioequivalence of carbamazepine chewable and conventional tablets: single-dose and steady-state studies.

  1985cited by this paper
• Area-dose relationships in nonlinear models

  1976cited by this paper
• Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics

  1973cited by this paper
• Finney, D. J.: Statistical method in biological assay. 2. Aufl. Charles Griffin & Cc. Ltd., London 1964. XIX + 668 S., Preis 105 s

  1965cited by this paper
• Statistical Method in Biological Assay

  1953cited by this paper

• Pharmacokinetics, Safety Profile, and Tolerability of MN-08 Tablets after Single and Multiple Ascending Doses in Healthy Chinese Volunteers.

  2026cites this paper
• A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant Recipients.

  2026cites this paper
• Pharmacokinetic study of Maloben after single and multiple doses in healthy volunteers

  2025cites this paper
• Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP‐8121)

  2025cites this paper
• Safety, Tolerability, Pharmacokinetics, and Effects of Gene Polymorphisms on Furaprevir (TG-2349), a Novel Hepatitis C Inhibitor: A Randomized Phase I Study

  2025cites this paper
• Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints.

  2025cites this paper
• A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG‐055009, a novel thyroid hormone receptor beta (THR‐β) agonist for metabolic dysfunction‐associated steatohepatitis (MASH), in healthy participants

  2025cites this paper
• Large Language Models for Clinical Trial Protocol Assessments

  2025cites this paper
• A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects

  2025cites this paper
• A Double‐Blind, Placebo‐Controlled, Single‐Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT‐101, an RNAi Therapeutic Targeting HBV Infection

  2025cites this paper
• Safety and pharmacokinetics of single and multiple doses of ledaborbactam etzadroxil with or without ceftibuten in healthy volunteers

  2025cites this paper
• Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529

  2025cites this paper
• Pharmacokinetics, tolerability, and safety of TBI-223, a novel oxazolidinone, in healthy participants

  2025cites this paper
• Pharmacokinetics of nikkomycin Z following multiple doses in healthy subjects

  2025cites this paper
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Firsekibart, an Anti-interleukin-1β Monoclonal Antibody, in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

  2025cites this paper
• Preclinical pharmacokinetics and tissue distribution of a polyhexamethylene guanidine derivative after ocular mucosal administration

  2025cites this paper
• Population pharmacokinetic modelling of oxytetracycline in rainbow trout (Oncorhynchus mykiss): Effects of route of administration, temperature and ploidy

  2025cites this paper
• Bioavailability and dose proportionality of a highly lipophilic phenolic antioxidant

  2025cites this paper
• Introduction to qualification and validation of an immunoassay

  2024cites this paper
• Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

  2024influential citation
• Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-Human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598.

  2024cites this paper
• Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies

  2024cites this paper
• Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients

  2024cites this paper
• First‐in‐Human Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of DISC‐0974, an Anti‐Hemojuvelin Antibody, in Healthy Participants

  2024cites this paper
• Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus

  2024cites this paper
• Pharmacokinetics and safety of TBAJ-876, a novel antimycobacterial diarylquinoline, in healthy subjects

  2024cites this paper
• First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults

  2024cites this paper
• First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus

  2024cites this paper
• First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus

  2024cites this paper
• Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study

  2024cites this paper
• CMG901, a Claudin18.2-specific antibody-drug conjugate, for the treatment of solid tumors

  2024cites this paper
• Population pharmacokinetics of a novel PCSK9 antisense oligonucleotide

  2024cites this paper
• Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men

  2024cites this paper
• First-in-Human Phase I Clinical Trial of the Adenosine A1R/A3R Agonist AST-004 in Healthy Subjects

  2024cites this paper
• Pharmacokinetics, Safety Profile, and Tolerability of Tetramethylpyrazine Nitrone Tablets After Single and Multiple Ascending Doses in Healthy Chinese Volunteers

  2024cites this paper
• Novel aspects of taxifolin pharmacokinetics: Dose proportionality, cumulative effect, metabolism, microemulsion dosage forms.

  2023cites this paper
• Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer

  2023cites this paper
• Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia

  2023cites this paper
• Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin

  2023cites this paper
• Pharmacokinetics of the novel 5-HT4 receptor agonist, DA-6886, in dogs

  2023cites this paper
• Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose–escalation study

  2023cites this paper
• A First-in-Human Study of Brozopentyl Sodium, following Single and Multiple Ascending Intravenous Infusion in Chinese Healthy Volunteers.

  2023cites this paper
• Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult participants

  2023cites this paper
• Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study

  2023cites this paper
• Pharmacokinetics and Tissue Distribution of Bee Venom-Derived Phospholipase A2 Using a Sandwich ELISA after Subcutaneous Injection of New Composition Bee Venom in Rats

  2023cites this paper
• Development and Validation of a Novel UHPLC-MS/MS Method for the Quantification of Plinabulin in Plasma and Its Application in a Pharmacokinetic Study with Leukopenic Rats

  2023cites this paper
• Evaluation of In Vivo Prepared Albumin-Drug Conjugate Using Immunoprecipitation Linked LC-MS Assay and Its Application to Mouse Pharmacokinetic Study

  2023cites this paper
• Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective autotaxin inhibitor, in healthy subjects: a phase I randomized placebo-controlled trial.

  2023cites this paper
• Abemaciclib does not increase the corrected QT interval in healthy participants

  2023cites this paper
• Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study

  2023cites this paper
• A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia

  2023cites this paper
• Safety, pharmacokinetics and pharmacodynamics of HWH486 capsules in healthy adults: A randomized, double-blind, placebo-controlled, phase I dose-escalation study.

  2023cites this paper
• Chemical composition, pharmacology and pharmacokinetic studies of GuHong injection in the treatment of ischemic stroke

  2023cites this paper
• A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease

  2022cites this paper
• Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial

  2022cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib

  2022cites this paper
• A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

  2022cites this paper
• A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults

  2022cites this paper
• A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ‐009

  2022cites this paper
• Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug Disposition

  2022cites this paper
• Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder

  2022cites this paper
• Plasma Protein Binding Rate and Pharmacokinetics of Lekethromycin in Rats

  2022cites this paper
• Safety and pharmacokinetic profile of pretomanid in healthy Chinese adults: Results of a phase I single dose escalation study.

  2022cites this paper
• First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

  2022cites this paper
• Pharmacokinetics of DA-6886, A New 5-HT4 Receptor Agonist, in Rats

  2022cites this paper
• Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study

  2022cites this paper
• Pharmacokinetics of single dose administration of three increasing doses of acetaminophen per os in 1-3-month-old foals.

  2022cites this paper
• First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects

  2022cites this paper
• Adamgammadex in patients to reverse a moderate rocuronium‐induced neuromuscular block

  2022cites this paper
• Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers

  2022cites this paper
• Pharmacokinetics, Tissue Distribution, and Excretion Characteristics of a Radix Polygoni Multiflori Extract in Rats

  2022cites this paper
• Results from in vitro and in vivo studies evaluating the bioavailability, effects of food, and administration as crushed tablet suspension on vericiguat pharmacokinetics

  2022influential citation
• Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects

  2022cites this paper
• Pharmacokinetics and clinical efficacy of Acetaminophen (Paracetamol) in adult horses with mechanically induced lameness.

  2022cites this paper
• Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study

  2022cites this paper
• Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of SY-004, a Glucokinase Activator, in Healthy Chinese Adults: A Randomized, Phase Ia, Single-Ascending Dose Study.

  2022cites this paper
• A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson ’ s Disease S

  2022cites this paper
• Assessment of pharmacokinetic linearity after repeated drug administration

  2022influential citation
• Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers

  2022cites this paper
• Safety, tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator PB-201 and its effects on the glucose excursion profile in drug-naïve Chinese patients with type 2 diabetes: a randomised controlled, crossover, single-centre phase 1 trial

  2021cites this paper
• Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study

  2021cites this paper
• Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection

  2021cites this paper
• Population pharmacokinetics/pharmacodynamics modelling of enrofloxacin for the three major trout pathogens Aeromonas salmonicida, Flavobacterium psychrophilum and Yersinia ruckeri

  2021influential citation
• First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

  2021cites this paper
• Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects

  2021cites this paper
• Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors

  2021cites this paper
• Pharmacokinetics, Urinary Excretion, and Pharmaco-Metabolomic Study of Tebipenem Pivoxil Granules After Single Escalating Oral Dose in Healthy Chinese Volunteers

  2021cites this paper
• Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach

  2021cites this paper
• A comparison of covariate selection techniques applied to pre-exposure prophylaxis (PrEP) drug concentration data in men and transgender women at risk for HIV

  2021cites this paper
• Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A

  2021cites this paper
• Absolute bioavailability, dose proportionality, and tissue distribution of rotundic acid in rats based on validated LC-QqQ-MS/MS method

  2021cites this paper
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cholic Acid (MT921) after a Subcutaneous Injection in the Submental Area to Humans

  2021cites this paper
• Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)

  2021cites this paper
• Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.

  2021cites this paper
• Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease

  2021cites this paper
• Pharmacokinetics and Safety of Dapoxetine Hydrochloride in Healthy Chinese Men: Impact of Dose and High‐Fat Meal

  2021cites this paper
• Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: a single-center, randomized, double-blind, placebo-controlled, single-dose phase I study.

  2021cites this paper
• Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export

  2021cites this paper
• Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers

  2021cites this paper
• Single‐ and Multiple‐Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies

  2020cites this paper